bepridil has been researched along with nifedipine in 63 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 34 (53.97) | 18.7374 |
1990's | 9 (14.29) | 18.2507 |
2000's | 11 (17.46) | 29.6817 |
2010's | 9 (14.29) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Creveling, CR; Daly, JW; Lewandowski, GA; McNeal, ET | 1 |
Dubinsky, B; Moore, JB; Press, JB; Sanfilippo, PJ; Urbanski, M | 1 |
Topliss, JG; Yoshida, F | 1 |
Keserü, GM | 1 |
Du, LP; Li, MY; Tsai, KC; Xia, L; You, QD | 1 |
Nagashima, R; Nishikawa, T; Tobita, M | 1 |
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
Jia, L; Sun, H | 1 |
García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
Sen, S; Sinha, N | 1 |
Cooper, J; Cui, Y; Fink, M; Gavaghan, DJ; Heath, BM; McMahon, NC; Mirams, GR; Noble, D; Sher, A | 1 |
Fijorek, K; Glinka, A; Mendyk, A; Polak, S; Wiśniowska, B | 1 |
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Chen, L; Fei, J; Mei, Y; Ren, S; Yan, SF; Zeng, J; Zhang, JZ | 1 |
Brown, AM; Bruening-Wright, A; Kramer, J; Kuryshev, YA; Myatt, G; Obejero-Paz, CA; Verducci, JS | 1 |
Brouillette, WJ; Brown, GB; Zha, C | 1 |
Crevat, A; Gallice, P; Kovacic, H | 1 |
Bourguignon, LY; Lokeshwar, VB | 1 |
DiBianco, R | 1 |
Baba, A; Matsuda, T; Shimizu, I | 1 |
Fabrègues, E; John, GW; Kamal, M; Massingham, R | 1 |
Haas, M; Punt, NC; van Amsterdam, FT; Zaagsma, J | 1 |
Kojima, M; Sperelakis, N | 1 |
Beckeringh, JJ; Hugtenburg, JG; Mathy, MJ; van Zwieten, PA | 1 |
Aidonidis, I; Brachmann, J; Dembowsky, K; Kuebler, W; Seller, H | 1 |
Cysouw, KJ; Lamers, JM; Verdouw, PD | 1 |
Balwierczak, JL; Grupp, G; Grupp, IL; Schwartz, A | 1 |
Brown, NL; Sirugue, O; Worcel, M | 1 |
Miller, RC; Schoeffter, P | 1 |
Adam, LP; Henderson, EG | 1 |
Baky, S; Nademanee, K; Singh, BN | 1 |
Boddeke, EW; Heynis, JB; Hugtenburg, JG; Jap, WT; Van Zwieten, PA; Veldsema-Currie, RD; Wilffert, B | 1 |
Zannad, F | 1 |
Beaughard, M; Lamar, JC; Piris, P; Tisne-Versailles, J | 1 |
Watts, JA | 1 |
Bowditch, J; Dow, JW; Nigdikar, SV | 1 |
Farmer, S; Marshall, RJ; Martorana, M; Winslow, E | 1 |
Beaughard, M; Lamar, JC; Michelin, MT; Tisne-Versailles, J | 1 |
Dang Tran, L; Gaillard, G; Montastruc, JL; Montastruc, P; Valet, P | 1 |
Balwierczak, J; Lathrop, DA; Matlib, MA; Schwartz, A | 1 |
Archer, SL; Chesler, E; Weir, EK; Yankovich, RD | 1 |
Humphreys, T; Lathrop, DA; Murphy, AM; Schwartz, A | 1 |
Martre, H; Singlas, E; Taburet, AM | 1 |
Hidaka, H; Ishikawa, T; Itoh, H | 1 |
Fosset, M; Galizzi, JP; Lazdunski, M | 1 |
Lazdunski, M; Méaux, JP; Renaud, JF; Romey, G; Schmid, A | 1 |
Pang, DC; Sperelakis, N | 3 |
Mras, S; Sperelakis, N | 1 |
Jespersen, LT; Mikkelsen, E; Pedersen, OL | 1 |
Goto, J; Sperelakis, N | 1 |
Advenier, C; Cerrina, J; Duroux, P; Floch, A; Renier, A | 1 |
Allain, P; Leblondel, G | 1 |
Barbier-Brygoo, H; Guern, J; Thomine, S; Van Duijn, B; Zimmerman, S | 1 |
Hamar, J; Perner, F; Szende, B; Toronyi, E | 1 |
Cascio, WE; Chowdhury, MK; Crouse, JR; Jollis, JG; Massing, MW; Simpson, RJ; Smith, SC | 1 |
Horiai, H; Ohtsuka, M; Oyanagui, Y | 1 |
Brown, AM; Ransom, BR; Wender, R | 1 |
Abe, J; Hamada, Y; Harada, T; Hashimoto, K; Horii, I; Sawada, Y; Shiotani, M | 1 |
Toronyi, E | 1 |
Hong, JM; Kim, J; Lee, SH; Ok, SH; Park, J; Shin, IW; Sohn, JT; Woo, MS | 1 |
4 review(s) available for bepridil and nifedipine
Article | Year |
---|---|
Bepridil treatment of chronic stable angina: a review of comparative studies versus placebo, nifedipine, and diltiazem.
Topics: Adult; Aged; Angina Pectoris; Bepridil; Chronic Disease; Diltiazem; Female; Humans; Male; Meta-Analysis as Topic; Middle Aged; Nifedipine | 1992 |
Second-generation calcium antagonists: search for greater selectivity and versatility.
Topics: Animals; Bepridil; Calcium Channel Blockers; Cinnarizine; Electrophysiology; Flunarizine; Heart; Humans; Lidoflazine; Muscle, Smooth, Vascular; Nicardipine; Nicotinic Acids; Nifedipine; Nimodipine; Nitrendipine; Pyrrolidines; Structure-Activity Relationship | 1985 |
[Clinical pharmacology of calcium inhibitors].
Topics: Age Factors; Animals; Bepridil; Biological Availability; Biotransformation; Calcium Channel Blockers; Diltiazem; Dogs; Half-Life; Humans; Intestinal Absorption; Kidney Failure, Chronic; Kinetics; Liver Diseases; Metabolic Clearance Rate; Nifedipine; Perhexiline; Protein Binding; Pyrrolidines; Rats; Tissue Distribution; Verapamil | 1985 |
[Role of apoptosis in the kidney after reperfusion].
Topics: Animals; Apoptosis; Bepridil; Calcium Channel Blockers; Disease Models, Animal; Fendiline; Humans; Kidney Transplantation; Kidney Tubules; Monoamine Oxidase Inhibitors; Nifedipine; Reperfusion Injury; Selegiline; Vasodilator Agents; Verapamil | 2008 |
59 other study(ies) available for bepridil and nifedipine
Article | Year |
---|---|
[3H]Batrachotoxinin A 20 alpha-benzoate binding to voltage-sensitive sodium channels: a rapid and quantitative assay for local anesthetic activity in a variety of drugs.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Anesthetics, Local; Animals; Batrachotoxins; Calcium Channel Blockers; Cyclic AMP; Guinea Pigs; Histamine H1 Antagonists; In Vitro Techniques; Ion Channels; Neurotoxins; Sodium; Tranquilizing Agents; Tritium | 1985 |
Synthesis of (aryloxy)alkylamines. 2. Novel imidazo-fused heterocycles with calcium channel blocking and local anesthetic activity.
Topics: Amines; Anesthetics, Local; Animals; Calcium Channel Blockers; Drug Evaluation, Preclinical; Heterocyclic Compounds; Imidazoles; In Vitro Techniques; Muscle Contraction; Muscle, Smooth; Myocardial Contraction; Rabbits; Trachea | 1988 |
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Prediction of hERG potassium channel affinity by traditional and hologram qSAR methods.
Topics: Cation Transport Proteins; Databases, Factual; Discriminant Analysis; Ether-A-Go-Go Potassium Channels; Holography; Linear Models; Potassium Channel Blockers; Potassium Channels; Potassium Channels, Voltage-Gated; Quantitative Structure-Activity Relationship | 2003 |
The pharmacophore hypotheses of I(Kr) potassium channel blockers: novel class III antiarrhythmic agents.
Topics: Anti-Arrhythmia Agents; Models, Biological; Models, Molecular; Potassium Channel Blockers; Potassium Channels; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2004 |
A discriminant model constructed by the support vector machine method for HERG potassium channel inhibitors.
Topics: Animals; CHO Cells; Cricetinae; Discriminant Analysis; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Humans; Potassium Channel Blockers; Potassium Channels, Voltage-Gated | 2005 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Support vector machines classification of hERG liabilities based on atom types.
Topics: Animals; Arrhythmias, Cardiac; CHO Cells; Computer Simulation; Cricetinae; Cricetulus; Discriminant Analysis; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Humans; Models, Chemical; Patch-Clamp Techniques; Potassium Channel Blockers; Potassium Channels, Voltage-Gated; Predictive Value of Tests; ROC Curve | 2008 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Predicting hERG activities of compounds from their 3D structures: development and evaluation of a global descriptors based QSAR model.
Topics: Computer Simulation; Ether-A-Go-Go Potassium Channels; Humans; Molecular Structure; Organic Chemicals; Quantitative Structure-Activity Relationship | 2011 |
Simulation of multiple ion channel block provides improved early prediction of compounds' clinical torsadogenic risk.
Topics: Action Potentials; Animals; Calcium Channel Blockers; Calcium Channels, L-Type; Computer Simulation; Dogs; Dose-Response Relationship, Drug; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Guinea Pigs; HEK293 Cells; Humans; Ion Channels; Kinetics; Models, Cardiovascular; NAV1.5 Voltage-Gated Sodium Channel; Patch-Clamp Techniques; Potassium Channel Blockers; Rabbits; Risk Assessment; Risk Factors; Sodium Channel Blockers; Sodium Channels; Torsades de Pointes; Transfection | 2011 |
Predictive model for L-type channel inhibition: multichannel block in QT prolongation risk assessment.
Topics: Artificial Intelligence; Calcium Channel Blockers; Calcium Channels, L-Type; Cell Line; Computational Biology; Computer Simulation; Drugs, Investigational; Ether-A-Go-Go Potassium Channels; Expert Systems; Heart Rate; Humans; Models, Biological; Myocytes, Cardiac; NAV1.5 Voltage-Gated Sodium Channel; Potassium Channel Blockers; Quantitative Structure-Activity Relationship; Risk Assessment; Shaker Superfamily of Potassium Channels; Torsades de Pointes; Voltage-Gated Sodium Channel Blockers | 2012 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Discovery and characterization of novel, potent, and selective cytochrome P450 2J2 inhibitors.
Topics: Chromatography, High Pressure Liquid; Cytochrome P-450 CYP2J2; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Discovery; Enzyme Inhibitors; Humans; Inhibitory Concentration 50; Kinetics; Microsomes, Liver; Models, Molecular; Molecular Dynamics Simulation; Substrate Specificity | 2013 |
MICE models: superior to the HERG model in predicting Torsade de Pointes.
Topics: ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Humans; Models, Theoretical; Patch-Clamp Techniques; Predictive Value of Tests; Torsades de Pointes | 2013 |
A highly predictive 3D-QSAR model for binding to the voltage-gated sodium channel: design of potent new ligands.
Topics: Ligands; Models, Molecular; Quantitative Structure-Activity Relationship; Voltage-Gated Sodium Channels | 2014 |
Inhibition of sodium pump by bepridil. An in vitro and microcalorimetric study.
Topics: Adenosine Triphosphate; Bepridil; Diltiazem; Erythrocytes; Humans; Kinetics; Nicardipine; Nifedipine; Ouabain; Potassium; Sodium-Potassium-Exchanging ATPase; Verapamil | 1992 |
The involvement of Ca2+ and myosin light chain kinase in collagen-induced platelet activation.
Topics: Bepridil; Calcium; Collagen; Cytoskeleton; Humans; Myosin-Light-Chain Kinase; Nifedipine; Phosphorylation; Platelet Activation; Serotonin; Sulfonamides | 1992 |
Na+ influx-induced decrease of (Na+ + K+)-ATPase activity in rat brain slices: role of Ca2+.
Topics: Amiloride; Animals; Bepridil; Brain; Calcium; Calcium Channel Blockers; Cell Membrane; Chelating Agents; Diazepam; Egtazic Acid; In Vitro Techniques; Kinetics; Male; Monensin; Nifedipine; omega-Conotoxins; Peptides, Cyclic; Quinacrine; Rats; Rats, Inbred Strains; Sodium; Sodium-Potassium-Exchanging ATPase; Verapamil; Veratrine | 1991 |
Caffeine-induced contractions in rabbit isolated renal artery are differentially inhibited by calcium antagonists.
Topics: Animals; Bepridil; Caffeine; Calcium Channel Blockers; Diltiazem; Dose-Response Relationship, Drug; Fendiline; Flunarizine; Kinetics; Lidoflazine; Male; Muscle Contraction; Muscle, Smooth, Vascular; Nifedipine; Rabbits; Renal Artery; Verapamil | 1991 |
Calcium antagonists show two modes of protection in ischemic heart failure.
Topics: Animals; Bepridil; Calcium Channel Blockers; Coronary Circulation; Coronary Disease; Diastole; Dose-Response Relationship, Drug; Male; Myocardial Contraction; Nifedipine; Rats; Rats, Inbred Strains; Verapamil | 1990 |
Effects of calcium channel blockers on ouabain-induced oscillatory afterpotentials in organ-cultured young embryonic chick hearts.
Topics: Action Potentials; Animals; Arrhythmias, Cardiac; Bepridil; Calcium Channel Blockers; Chick Embryo; Diltiazem; Ion Channels; Nifedipine; Organ Culture Techniques; Ouabain; Pyrrolidines; Verapamil | 1986 |
The differential effect of calcium antagonists on the positive inotropic effects induced by calcium and monensin in cardiac preparations of rats and guinea-pigs.
Topics: Animals; Bepridil; Calcium; Calcium Channel Blockers; Diltiazem; Gallic Acid; Heart Ventricles; Lidoflazine; Male; Monensin; Myocardial Contraction; Nifedipine; Papillary Muscles; Rats; Rats, Inbred Strains; Ryanodine; Stimulation, Chemical; Verapamil | 1989 |
Bepridil versus nifedipine for ventricular tachycardia induced in the late postinfarction phase in conscious dogs.
Topics: Animals; Bepridil; Calcium Channel Blockers; Cardiac Pacing, Artificial; Consciousness; Dogs; Electrocardiography; Myocardial Infarction; Nifedipine; Pyrrolidines; Tachycardia | 1989 |
Slow calcium channel blockers and calmodulin. Effect of felodipine, nifedipine, prenylamine and bepridil on cardiac sarcolemmal calcium pumping ATPase.
Topics: Animals; Bepridil; Calcium; Calcium Channel Blockers; Calcium-Transporting ATPases; Calmodulin; Felodipine; In Vitro Techniques; Myocardium; Nifedipine; Phosphodiesterase Inhibitors; Prenylamine; Pyrrolidines; Sarcolemma; Swine | 1985 |
Effects of bepridil and diltiazem on [3H]nitrendipine binding to canine cardiac sarcolemma. Potentiation of pharmacological effects of nitrendipine by bepridil.
Topics: Animals; Benzazepines; Bepridil; Binding Sites; Binding, Competitive; Diltiazem; Dogs; Drug Synergism; In Vitro Techniques; Kinetics; Myocardial Contraction; Nifedipine; Nitrendipine; Pyrrolidines; Rats; Sarcolemma; Temperature | 1986 |
The effects of some slow channel blocking drugs on high affinity serotonin uptake by rat brain synaptosomes.
Topics: Animals; Bepridil; Brain; Calcium Channel Blockers; Diltiazem; In Vitro Techniques; Male; Nifedipine; Nitrendipine; Pyrrolidines; Rats; Rats, Inbred Strains; Serotonin; Synaptosomes; Temperature; Time Factors; Verapamil | 1986 |
Role of sodium-calcium exchange and effects of calcium entry blockers on endothelial-mediated responses in rat isolated aorta.
Topics: Amiloride; Animals; Aorta; Bepridil; Calcium; Calcium Channel Blockers; Choline; Cyclic GMP; Diltiazem; Endothelium; Female; Lithium; Muscle, Smooth, Vascular; Nicergoline; Nifedipine; Pyrrolidines; Rats; Rats, Inbred Strains; Reserpine; Sodium; Verapamil | 1986 |
Augmentation of succinylcholine-induced neuromuscular blockade by calcium channel antagonists.
Topics: Animals; Bepridil; Calcium Channel Blockers; Drug Synergism; In Vitro Techniques; Neuromuscular Junction; Nicardipine; Nifedipine; Pyrrolidines; Rana pipiens; Receptors, Nicotinic; Succinylcholine; Synaptic Transmission; Verapamil | 1986 |
The anti-ischaemic activity of the novel compound, CERM 11956, compared with that of bepridil and nifedipine in isolated guinea-pig hearts.
Topics: Adenosine Triphosphate; Animals; Bepridil; Calcium Channel Blockers; Coronary Circulation; Coronary Disease; Female; Guinea Pigs; In Vitro Techniques; Male; Myocardial Contraction; Nifedipine; Phosphocreatine; Pyrrolidines | 1988 |
[Pharmacology of calcium antagonists].
Topics: Bepridil; Calcium Channel Blockers; Cardiovascular System; Diltiazem; Nifedipine; Pyrrolidines; Verapamil | 1988 |
Effects of bepridil and nifedipine on regional myocardial contractility during ischaemia in anaesthetized dogs.
Topics: Anesthesia; Animals; Bepridil; Coronary Circulation; Coronary Disease; Dogs; Myocardial Contraction; Nifedipine; Pyrrolidines; Ultrasonics | 1986 |
Protection of ischemic hearts by Ca2+ antagonists.
Topics: Animals; Bepridil; Calcium; Calcium Channel Blockers; Coronary Disease; Diltiazem; Energy Metabolism; Lactates; Lactic Acid; Mitochondria, Heart; Myocardial Contraction; Nifedipine; Pyrrolidines; Rats; Rats, Inbred Strains; Verapamil | 1986 |
Calcium antagonists and adenine nucleotide metabolism in rat heart.
Topics: Adenine Nucleotides; Adenosine Triphosphate; Animals; Bepridil; Calcium Channel Blockers; Heart; Myocardium; Nifedipine; Nisoldipine; Pyrrolidines; Rats; Verapamil | 1986 |
The effects of bepridil compared with calcium antagonists on rat and rabbit aorta.
Topics: Animals; Aorta, Thoracic; Bepridil; Calcium Channel Blockers; In Vitro Techniques; Male; Muscle Relaxation; Muscle, Smooth, Vascular; Nifedipine; Nisoldipine; Phenylephrine; Potassium; Pyrrolidines; Rabbits; Rats; Species Specificity | 1986 |
Comparative effects of bepridil, diltiazem, nifedipine and verapamil on haemodynamic parameters and myocardial oxygen consumption in anaesthetized dogs.
Topics: Animals; Bepridil; Calcium Channel Blockers; Coronary Circulation; Diltiazem; Dogs; Female; Heart; Hemodynamics; Male; Myocardium; Nifedipine; Oxygen Consumption; Pyrrolidines; Vascular Resistance; Verapamil | 1986 |
Effects of calcium entry blockers on blood pressure and heart rate in neurogenic hypertensive dogs.
Topics: Animals; Bepridil; Blood Pressure; Calcium Channel Blockers; Denervation; Diltiazem; Dogs; Female; Heart Rate; Hypertension; Male; Nicardipine; Nifedipine; Pyrrolidines; Sinoatrial Node; Verapamil | 1987 |
Pharmacology of calcium antagonists.
Topics: Action Potentials; Animals; Atrioventricular Node; Bepridil; Calcium Channel Blockers; Coronary Vessels; Diltiazem; Guinea Pigs; Heart; Heart Rate; Humans; Muscle, Smooth, Vascular; Myocardial Contraction; Nifedipine; Pyrrolidines; Rats; Vasodilation; Ventricular Fibrillation; Verapamil | 1985 |
Comparative effects of nisoldipine, nifedipine and bepridil on experimental pulmonary hypertension.
Topics: Animals; Bepridil; Blood Gas Analysis; Calcium Channel Blockers; Dinoprost; Dogs; Female; Hemodynamics; Hypertension, Pulmonary; Hypoxia; Male; Nifedipine; Nisoldipine; Prostaglandins F; Pyrrolidines | 1985 |
Effects of bepridil on force development and transmembrane electrical activity of adult canine Purkinje strands: comparison with nisoldipine and lidocaine.
Topics: Animals; Bepridil; Calcium Channel Blockers; Dogs; Female; Heart Conduction System; Lidocaine; Male; Membrane Potentials; Nifedipine; Nisoldipine; Purkinje Fibers; Pyrrolidines; Time Factors | 1985 |
Effects on calmodulin of bepridil, an antianginal agent.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Anti-Arrhythmia Agents; Bepridil; Calmodulin; Cattle; Chickens; Drug Interactions; Gizzard, Avian; Male; Muscle Contraction; Muscle, Smooth, Vascular; Myosin-Light-Chain Kinase; Nifedipine; Phosphorylation; Protein Kinases; Pyrrolidines; Rabbits; Sulfonamides | 1984 |
Properties of receptors for the Ca2+-channel blocker verapamil in transverse-tubule membranes of skeletal muscle. Stereospecificity, effect of Ca2+ and other inorganic cations, evidence for two categories of sites and effect of nucleoside triphosphates.
Topics: Animals; Bepridil; Binding, Competitive; Calcium; Calcium Channels; Cations, Divalent; Cations, Monovalent; Diltiazem; Electrochemistry; Guanosine Triphosphate; Guanylyl Imidodiphosphate; Hydrogen-Ion Concentration; In Vitro Techniques; Muscles; Nifedipine; Nitrendipine; Nucleotides; Pyrrolidines; Rabbits; Receptors, Nicotinic; Stereoisomerism; Verapamil | 1984 |
Activation of the voltage-dependent Ca2+ channel in rat heart cells by dihydropyridine derivatives.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Bepridil; Calcium; Dose-Response Relationship, Drug; Ion Channels; Myocardium; Nifedipine; Pyridines; Pyrrolidines; Rats; Rats, Inbred Strains; Time Factors; Verapamil | 1984 |
Nifedipine, diltiazem, bepridil and verapamil uptakes into cardiac and smooth muscles.
Topics: Animals; Benzazepines; Bepridil; Calcium Channel Blockers; Cats; Chick Embryo; Diltiazem; Ileum; In Vitro Techniques; Muscle, Smooth; Myocardium; Nifedipine; Papillary Muscles; Pyridines; Pyrrolidines; Rabbits; Time Factors; Verapamil | 1983 |
Depression of contractions of rabbit aorta and guinea pig vena cava by mesudipine and other slow channel blockers.
Topics: Animals; Aorta, Thoracic; Bepridil; Calcium Channel Blockers; Diltiazem; Dose-Response Relationship, Drug; Guinea Pigs; Muscle Contraction; Muscle, Smooth, Vascular; Nifedipine; Potassium; Pyridines; Pyrrolidines; Rabbits; Vena Cava, Inferior; Verapamil | 1983 |
Uptake of calcium antagonistic drugs into muscles as related to their lipid solubilities.
Topics: Animals; Bepridil; Calcium Channel Blockers; Lipid Metabolism; Muscles; Nifedipine; Nitrendipine; Pyrrolidines; Rana pipiens; Rats; Sarcoplasmic Reticulum; Solubility; Verapamil | 1984 |
Effects of two new Ca-entry blockers bepridil and nitrendipine on isolated vessels.
Topics: Adult; Aged; Animals; Aorta, Thoracic; Bepridil; Calcium Channel Blockers; Female; Femoral Vein; Humans; In Vitro Techniques; Leg; Male; Middle Aged; Muscle Contraction; Muscle, Smooth, Vascular; Nifedipine; Nitrendipine; Norepinephrine; Portal Vein; Potassium; Pyrrolidines; Rats; Veins | 1984 |
Depression of automaticity of the rabbit SA node by bepridil and nifedipine.
Topics: Animals; Anti-Arrhythmia Agents; Bepridil; In Vitro Techniques; Kinetics; Membrane Potentials; Microelectrodes; Nifedipine; Pyrrolidines; Rabbits; Sinoatrial Node; Time Factors | 1984 |
Effects of five different organic calcium antagonists on guinea-pig isolated trachea.
Topics: Animals; Anti-Arrhythmia Agents; Bepridil; Calcium Channel Blockers; Diltiazem; Dose-Response Relationship, Drug; Guinea Pigs; In Vitro Techniques; Male; Muscle Contraction; Muscle Relaxation; Muscle, Smooth; Nicardipine; Nifedipine; Pyrrolidines; Trachea; Verapamil | 1984 |
Ca2+ uptake and energy supply of sheep heart mitochondria in presence of some calcium antagonists.
Topics: Animals; Bepridil; Calcium; Calcium Channel Blockers; Diltiazem; Energy Metabolism; Mitochondria, Heart; Nifedipine; Prazosin; Pyrrolidines; Sheep | 1984 |
Differential actions of calcium antagonists on calcium binding to cardiac sarcolemma.
Topics: Animals; Bepridil; Binding Sites; Calcium; Calcium Channel Blockers; Diltiazem; Guinea Pigs; In Vitro Techniques; Myocardium; Nifedipine; Pyrrolidines; Sarcolemma; Verapamil | 1982 |
Calcium channel antagonists induce direct inhibition of the outward rectifying potassium channel in tobacco protoplasts.
Topics: Bepridil; Calcium Channel Blockers; Cell Membrane; Cells, Cultured; Membrane Potentials; Nicotiana; Nifedipine; Plants, Toxic; Potassium Channel Blockers; Protoplasts; Verapamil | 1994 |
Prevention of apoptosis reperfusion renal injury by calcium channel blockers.
Topics: Animals; Apoptosis; Bepridil; Calcium Channel Blockers; Fendiline; Kidney; Kidney Tubules; Male; Nifedipine; Rats; Rats, Wistar; Reperfusion Injury; Severity of Illness Index; Time Factors; Verapamil | 1999 |
Calcium channel blockers and mortality in elderly patients with myocardial infarction.
Topics: Aged; Aged, 80 and over; Amlodipine; Bepridil; Calcium Channel Blockers; Diltiazem; Female; Humans; Logistic Models; Male; Myocardial Infarction; Nifedipine; Retrospective Studies; Severity of Illness Index; Time Factors; Treatment Outcome; United States; Verapamil | 1999 |
Effect of nilvadipine in weak acidic medium by 1,1-diphenyl-2-picrylhydrazyl (DPPH) assay.
Topics: Amlodipine; Anticholesteremic Agents; Antioxidants; Bepridil; beta Carotene; Biphenyl Compounds; Buffers; Calcium Channel Blockers; Free Radicals; Hydrogen-Ion Concentration; Nifedipine; Picrates; Probucol | 2001 |
Ionic mechanisms of aglycemic axon injury in mammalian central white matter.
Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; Action Potentials; Animals; Axons; Bepridil; Calcium; Calcium Channel Blockers; Calcium Channels, L-Type; Diltiazem; Electrophysiology; Excitatory Amino Acid Antagonists; Extracellular Space; Glucose; Kynurenic Acid; Mammals; Nifedipine; Optic Nerve; Optic Nerve Diseases; Rats; Rats, Long-Evans; Receptors, N-Methyl-D-Aspartate; Sodium; Sodium-Calcium Exchanger | 2001 |
Practical application of guinea pig telemetry system for QT evaluation.
Topics: Animals; Anti-Arrhythmia Agents; Antipsychotic Agents; Bepridil; Cisapride; Disease Models, Animal; Electrocardiography; Guinea Pigs; Haloperidol; Heart; Humans; Injections, Intravenous; Long QT Syndrome; Male; Nifedipine; Pimozide; Piperidines; Pyridines; Quinidine; Reproducibility of Results; Telemetry; Terfenadine; Thioridazine | 2005 |
Lipid emulsion alleviates the vasodilation and mean blood pressure decrease induced by a toxic dose of verapamil in isolated rat aortae and an in vivo rat model.
Topics: Animals; Aorta, Thoracic; Bepridil; Blood Pressure; Calcium Channel Blockers; Diltiazem; Emulsions; In Vitro Techniques; Male; Nifedipine; Phenylephrine; Phospholipids; Rats; Rats, Sprague-Dawley; Soybean Oil; Vasodilation; Vasodilator Agents; Verapamil | 2018 |